A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has ...

Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies.

Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model ...

A Step Closer to the Confident Production of Blood Stem Cells for Regenerative Medicine May 16, 2025 — Researchers have developed a method to confidently produce blood cell precursors from stem ...

Stem cells can produce any other cell type, it is just a matter of telling them in the right way. From a biological ...

This hybrid technology has the potential to transform treatments for neurodegenerative diseases by enhancing the precision and efficacy of stem cell-based therapies. The study's core innovation ...

Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank Mesoblast for inspiring the third.

This is almost the case with stem cells. In a new study, researchers from the University ... “We hope to improve IVF technology by developing a culture for IVF that uses the same metabolic process.

This hybrid technology has the potential to transform treatments for neurodegenerative diseases by enhancing the precision and efficacy of stem cell-based therapies. The study's core innovation ...

The promise of regenerative medicine through stem-cell therapy is intoxicating. Stem-cell lines are pluripotent (that is, they can develop into various cell types); they are self-renewable ...

Twenty years ago, the use of human embryonic stem cells in research was among the most fiercely debated topics at the always-crowded intersection of science and politics. As part of that ...